Sweden · Delayed Price · Currency is SEK Arcoma AB Statistics
Total Valuation
Arcoma AB has a market cap or net worth of SEK 121.91 million. The enterprise value is 87.97 million.
| Market Cap | 121.91M |
| Enterprise Value | 87.97M |
Important Dates
The next confirmed earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Arcoma AB has 14.31 million shares outstanding. The number of shares has increased by 10.65% in one year.
| Current Share Class | 14.31M |
| Shares Outstanding | 14.31M |
| Shares Change (YoY) | +10.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.26% |
| Owned by Institutions (%) | n/a |
| Float | 11.93M |
Valuation Ratios
The trailing PE ratio is 32.74 and the forward PE ratio is 12.72.
| PE Ratio | 32.74 |
| Forward PE | 12.72 |
| PS Ratio | 0.96 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 5.83 |
| P/OCF Ratio | 5.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.64, with an EV/FCF ratio of 4.21.
| EV / Earnings | 23.17 |
| EV / Sales | 0.69 |
| EV / EBITDA | 19.64 |
| EV / EBIT | 19.19 |
| EV / FCF | 4.21 |
Financial Position
The company has a current ratio of 3.12
| Current Ratio | 3.12 |
| Quick Ratio | 2.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 41.30 |
Financial Efficiency
Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 9.05%.
| Return on Equity (ROE) | 5.55% |
| Return on Assets (ROA) | 2.95% |
| Return on Invested Capital (ROIC) | 9.05% |
| Return on Capital Employed (ROCE) | 6.07% |
| Weighted Average Cost of Capital (WACC) | 7.77% |
| Revenue Per Employee | 4.10M |
| Profits Per Employee | 122,484 |
| Employee Count | 31 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, Arcoma AB has paid 948,000 in taxes.
| Income Tax | 948,000 |
| Effective Tax Rate | 19.98% |
Stock Price Statistics
The stock price has decreased by -13.06% in the last 52 weeks. The beta is 0.64, so Arcoma AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -13.06% |
| 50-Day Moving Average | 8.37 |
| 200-Day Moving Average | 8.17 |
| Relative Strength Index (RSI) | 47.45 |
| Average Volume (20 Days) | 10,274 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arcoma AB had revenue of SEK 127.06 million and earned 3.80 million in profits. Earnings per share was 0.26.
| Revenue | 127.06M |
| Gross Profit | 50.63M |
| Operating Income | 4.58M |
| Pretax Income | 4.75M |
| Net Income | 3.80M |
| EBITDA | 4.48M |
| EBIT | 4.58M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 33.94 million in cash and n/a in debt, with a net cash position of 33.94 million or 2.37 per share.
| Cash & Cash Equivalents | 33.94M |
| Total Debt | n/a |
| Net Cash | 33.94M |
| Net Cash Per Share | 2.37 |
| Equity (Book Value) | 75.54M |
| Book Value Per Share | 5.28 |
| Working Capital | 55.70M |
Cash Flow
In the last 12 months, operating cash flow was 21.35 million and capital expenditures -449,000, giving a free cash flow of 20.91 million.
| Operating Cash Flow | 21.35M |
| Capital Expenditures | -449,000 |
| Depreciation & Amortization | -105,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 20.91M |
| FCF Per Share | 1.46 |
Margins
Gross margin is 39.84%, with operating and profit margins of 3.61% and 2.99%.
| Gross Margin | 39.84% |
| Operating Margin | 3.61% |
| Pretax Margin | 3.73% |
| Profit Margin | 2.99% |
| EBITDA Margin | 3.53% |
| EBIT Margin | 3.61% |
| FCF Margin | 16.45% |
Dividends & Yields
Arcoma AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.65% |
| Shareholder Yield | -10.65% |
| Earnings Yield | 3.11% |
| FCF Yield | 17.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |